T-Lymphocyte Clones Initiated from Lesional Psoriatic Skin Release Growth Factors that Induce Keratinocyte Proliferation  by Strange, Poul et al.
T -Lymphocyte Clones Initiated from Lesional 
Psoriatic Skin Release Growth Factors that Induce 
Keratinocyte Proliferation 
paul Strange,* Kevin D. Cooper,t Erik R. Hansen,* Gary FisherJ Jorgen K. Larsen,t David Fox,§ 
Christen Krag, ~ John J. Voorhees, t and O le Baadsgaard * 
Departments of 'De~matology, Gentofte Hospital, Univ~rsi.ty of Copenhag~n, Denmark; Departments.of tDermatology and 
§Rheumatology, Ul11vemty of Mlclugan, Ann Arbor, Mlclugan, U.S.A.; :j:Fll1sen Laboratory ,. R,gshospltalet, Ul11vemty of 
Copenhagen, Denmark; and ~Department of Reconstructive Surgery, Gentofte Hospital, Ul1lVerslty of Copenhagen, Denmark 
To investigate whether growth factors derived from T cells 
in psoriatic lesions .ar~ .able to stimula.te keratin<:>c~te g~owth, 
T-cell lines were InItiated from leslOnal psonasls skill and 
cloned by limiting dilution. Eight clones wi~h good pro~ifer­
ative capacity out of 40 clones from one patient were stimu-
lated. After 24 h, the conditioned medium was harvested and 
the growth modulatory effect of the condi~ioned medium on 
keratinocytes was assessed. Seven of the eight T-cell clones 
stimulated keratinocyte growth to an extent ranging from 
22% ± 19 to 64% ± 9 (mean ± SD of three experiments) of 
maximal inducible keratinocyte growth, and one T-cell 
clone had no effect (- 5% ± 2) on keratinocyte growth. Ke-
T he immune system has long been suggested to play an essential role in the pathogenesis of p~oriasis [1]. Ob-servations supportive of this hypotheSIS are numerous. First, psoriasis exhibits a strong association with par-ticular human leukocyte antigen (HLA) types [2], 
which is a feature of many autoimmune diseases. Second, t~e ~p!­
dermal hyperplasia that is the key clinical feature of psonaSlS IS 
preceded by invasion of the skin by mononucl.ear ~ells, esp.eClal!y 
activated T cells [3]. Third, the drug cyclosponn A IS efficaclO~s In 
the treatment of psoriasis [4]. Concentrations of cyclosponn A 
present in the skin ill "iva during psoriasis therapy. (14 mg/~g/d) 
block T-cell release of cytokines [5] and the function of antlgen-
presenting cells [6,7], whereas the dru~ does no~ inhibit ke~atino­
eyte grow~h ill vitro [8] . T.hese observations prOVide strong Circum-
stantial eVidence that the Immune system plays a pIvotal role In the 
pathogenesis of psoriasis. However, direct evidence that cell.s from 
the immune system induce keratinocyte hyperprohferatlon In pso-
riasis is still lacking. The purpose of the present study was therefore 
to investigate whether T cells could be involved in the pathogenesis 
of psoriasis by direct stimulation ofkeratinocyte growth. We show 
that T-cell clones initiated from lesional psoriatic skin indeed have 
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ratinocyte growth was also induced by T-cell clones obtained 
from two other patients . 
Several cytokines were tested in this system to determine 
which T-cell growth factor may induce the keratinocyte 
growth. None of the cytokines interferon-g, transforming 
growth factor-p, interleukin (IL}-2, IL-3, IL-4, IL-6, IL-8, or 
granulocyte-macrophage colony stimulating factor alone 
was found to possibly be responsible for the T -cell- induced 
keratinocyte growth. Thus the nature of the T -cell keratino-
cyte growth-promoting stimulus remains to be elucidated. 
Key words: psoriasis/IL-3/GM-CSF. ] Imlest Dermatol 
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the capacity to release growth factors that directly stimulate kerati-
nocyte growth. 
MATERIALS AND METHODS 
T-Cell Lines Initiated from Lesional Psoriasis A 4-mm punch biopsy 
was taken from involved skin from patients with typical expanding psoriasis 
vulgaris. The biopsy was washed extensively and was cut as close to the 
dermal-epidermal junction as possible. The epidermis was cut in many small 
pieces and incubated in RPM I 1640 supplemented with 5% AB-serum 
(Sigma, St. Louis, MO) and 5% purified IL-2 (Pharmacia, Silver Spring, 
MD) .. After24 h many T cells were present in the medium and the fragments 
of epidermIS were removed. After less than 1 week, the T-cell lines were 
cloned by standard procedures using gamma-irradiated autologous mononu-
clear cells from blood as feeder cells as previously described [9]. It has previ-
ously been. shown by Southern blot analysis of the T-cell receptor region that 
clones denvl1lg from one mother T cell are obtained using this method [9], 
hence they are termed T-cell clones in this paper. 
Stimulation ofT-Cell Clones in Lesional Psoriatic Skin The T-cell 
clones wer~ cultured in serum-free medium AIM V (GIBCO, Paisley, Scot-
land) at 10 .cells/mlm 1 mlm 24-well tissure culture plates. The T-cell 
activatIOn stm1Ulus used was the monoclonal antibody UM4D4 that binds to 
the struc.ture d.es 'gnated CDw60 and is termed anti-CDw60 in this paper. 
StimulatIOn With antl-C!?w60 results in T-cell activation and cytokille re-
lease (10]. CDw60-posltlve T cells are compartmentalized in psoriatic le-
sions where 75% of the T .cells are CDw60 positive in contrast to only 20% 
CDw60-posltlve T cells 111 peripheral blood [4]. To stimulate the T-cell 
clones denved from leslOnal psoriatic skin through CDw60 may thus be 
relevant to the itl vivo activation, therefore anti-CDw60 was used as the 
stimulus for the T-cell clones. In some experiments, a combination of phy-
tohemagglutinin (PHA)(1 .ug/ ml) and phorbol myristate acetate (PMA)(3 
ng/ml) was used as the T-cell stimulus. After 2-4 h the cells were washed 
three times, resuspended at 106 cells/ml in fresh medium supplemented with 
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Figure 1. Correlation between number ofkeratinocytes seeded and relative 
fluorescence intensity (RFU). Kerannocytes were seeded In a flat-bottomed 
microtiter plate and allowed to attach for 6 h. After two washes the keratino-
cytes were incubated with 50 ,ug/ ml methyl-umbelliferone-heptanoate at 
37 ' C for 30 min. The RFU at 450 nm aftcr ultraviolet radiation excitation at 
365 nm was read. Bars, mean ± SO of triplicate determinations; dotted lil/e, 
linear regression line. T he relative fluorescent units is a very good estimate of 
relative cell number. Representative experiment of two. 
2 U /ml rhIL-2, and incubated as described above in a new tissue cultnre 
plate . Concurrently, control medium also containing rhIL-2 was incubated. 
After 24 h the supernatant was harvested and spun at 1000 X g for 30 min to 
clear all cel ls and debris, and was storcd at -80 'C for later use. 
Cultivation of Keratinocytes Primary cultures of keratinocytes were 
initiated from patients undergoing reduction mammoplasty and were cul-
tured in serum-free medium keratinocyte growth medium (KGM; Clone-
tics, San Diego, CAl by standard methods that eliminate cell types other than 
keratinocytes [11]. The keratinocytes were used for assay after three to four 
passages. 
Keratinocyte Growth Assay The serum-free keratinocyte medium con-
sisted of a chemically defined basal medium keratinocyte basal medium 
(KBM) that supports minimal or no growth ofkeratinocytes. The KBM was 
supplemented with suboptimal concentrations of growth factors: hydrocor-
tisone (10 nl/ml), insulin (100 nl/ml), and bovine pituitary extract (1.0-1.3 
,ug/ml), below termed semicomplete keratinocyte medium (SKBM). SKBM 
was used because it permits both up- and down-regulation of keratinocyte 
proliferation (12] . 
Determination of Keratinocyte Growth Using a Fluorometric Ass-
ay To assess keratinocyte growth we used a slight modification of a fluor-
ometric method developed by Detmar el al [13]. Two or three thousand 
keratinocytes were seeded in flat-bottom microtiter plates in SKBM with 
va.rying dilutions of the T-cell supernatant or recombinant cytokine to be 
tested for keratinocyte growth-modulatory property. After 3 d the micro-
titer plates were washed twice and incubated with methyl-umbelliferone-
heptanoate (Sigma) at 50 ,ug/ml in phosphate-buffered saline (PBS) . After 
30 min at 37 ' C the relative fluorescence intensity (RFU) at 450 nm after 
ultraviolet radiation excitation at 365 nm was read using a Microfluor reader 
(Dynatech Laboratories, Chanti lly, VA). The coefficient of correlation be-
tween RFU and the number of keratinocytes seeded and allowed to attach 
for 6 h was r2 > 0.99 (F ig 1). 
Counting of Keratinocytes Using a Hemocytometer Keratinocytes 
were seeded in 6-well plates at the same density in each well and grown to 
semiconfluence in KGM, switched to SKBM for 24 h, and finally switched 
to T -cell - conditioned medium or added in 1 : 5 concentration to SKBM. 
After 3 d the cells were harvested and counted in a hemocytometer. 
T-Cell Lines, Cytokines. and Cytokine Assays The T-cell lines 
MOLT -4 [14] and CEM [15] were obtained from the American Type Cul-
ture Collection (Rockville, MD) and C91/PL [16] was kindly provided by 
Claus Nielsen, Statens Seruminstitut, Copenhagen, Denmark. The cyto-
kines rhIL-3, rhGM-CSF, rhIL-4, rhIL-6, and rhIFN-g were obtained from 
Genzyme (Cambridge, MA), rh lL-2 was from Cetus and rhlL-8 was from 
Endogen (Boston, MA). The B9 hybridoma cells for the IL-6 bioassay were 
kindly provided by Dr. Aarden, Central Laboratory of the Netherlands Red 
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Figure 2. T -cell clones from involved psoriatic epidermis vary in their 
keratinocyte growth-modulatory capacity. Each T-cell clone was stimulated 
with anti-CDw60 in two or three separate experiments. The T -cell clone 
supernatants were tested for keratinocyte growth induction in several dilu-
tions from 1 : 5 to 1 : 200,000. After 3 d incubation the relative ke ratinocyte 
ccl l number was estimated using the fluorometric assay. The stimulation of 
the keratinocytcs by the supernatants in the dilution 1 : 5 was calculated as 
percent of maximal inducible keratinocyte growth, i.e., keratinocytc stimu-
lation in completely growth-factor-supplemented medium KGM (-'- '-" 
100% growth). The arithmetic mean ± SO of these individually deter-
mined growth- induction percentages from each T-cell clone were calcu-
lated and are expressed on the y-axis . 
Cross Blood Transfusion Service. The assay was performed as described by 
Aarden el al [17] and the rhlL-6 was found to be biologically active. 
Cytokine contents were determined by radioimmunoassay (RIA) and en-
zyme-linked immunosorbent assay (ELISA) kits. The TGF-a RIA kit was 
obtained from Biomedical Technologies Inc. (Stoughton, MA), the IL-3 
ELISA kit was from R&D Systems (Minneapolis, MN), and the granulo-
cyte-macrophage colony stimulating factor (GM-CSF) ELISA kit was from 
Genzyme. 
RESULTS 
T -Cell Clones Derived from Lesional Psoriatic Skin Stimu-
late Keratinocyte Growth From one psoriasis patient 40 le-
sional T -cell clones were obtained. Eight of these T-cell clones 
grew sufficiently well to be used in experiments. All eight T-cell 
clones were CDw60+ and responded to anti-CDw60 by aggregat-
ing in clusters within 3 h. Each of these T-cell clones was stimulated 
with anti-CDw60 in two or three separate experiments. The super-
natants from each experiment were tested for their keratinocyte 
growth-modulatory property. Seven T -cell clones were reproduci-
bly found to stimulate keratinocyte growth and one T-cell clone 
had no effect on keratinocyte growth (Fig 2). All but one of the 
T-cell clones (PSIK1) were immunostained for CD4/CD8 expres-
sion and they were all found to be CD4+. The T-cell clones were 
CD8- except PS1K15, which showed contamination with < 1 % 
CD8+ cells, indicating that it is an oligoclone. 
To better characterize the growth-promoting effect. one well 
growing T-cell clone derived from lesional psoriatic skin that in-
duced keratinocyte proliferation was further studied. The superna-
tant from this T-cell clone was tested on three different keratinocyte 
sources and induced proliferation in all of them. This is shown in 
Fig 3, where the left, middle, and right curves show the dose-
response curve of added T-cell supernatant to the different kerati-
nocyte sources. The potencies of the supernatant on the adult kerat-
inocyte sources (at 20% di lution) (mean ± SD) left figure. 54% ± 
19; middle figure, 65% ± 29 and the neonate keratinocytes (at 30% 
di lution). right figure, 41 % ± 3 were approximately the same. 
Thus the ability of the T cells to stimulate keratinocyte growth 
seems to be independent of the keratinocyte source. 
T-cell lines were initiated and T-cell clones were obtained from 
involved skin of two other patients with typica l psoriasis vulgaris. 
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Figure 3. T-ceIl stimulation of keratinocyte growth is independent of 
keraeinocyte source. The T-cell supernatant (--) and con~rol medlllm 
( ___ ) w ere tested for keratinocyte growth induction on the different kerati-
ocyte sources using the fluorometric assay. The keratinocytes used in the 
~ and middle wrves were normal human adult and the keratinocytes used in 
the right wrve were normal human neonate. The dilution of the supernatant 
d control medium is depicted on the x-axis and the relative fluo rescence 
(directly proportional to ce ll number) on the y-axis: -'-'- ' , maximal kerat-
. ocyee growth in completely supplemented keratll10cyte medIum (KGM); 
~ .. _ . . _ .. - .. -, keratinocyte growth in semicompleted medium (SKBM). 
Error bars, mean ± SD of triplicate well determinations. 
The T-ceJl cl o nes w ere also stimul ated with anti-CDw60 and th e 
supe rnatants w ere test.ed for keratinocyte growth-modulatory 
pro p e rties. In both patients T-cell clones that stimulated T-cell 
gro wth w ere present. Supernatant w as harvested from one of these 
T-cell clones after 24, 48, and 72 h . The dose-response curves of the 
kera tinocyte growth-stimulatin g effects of these supernatants har-
vest e d at different times after stimulation with antl-CDw60 are 
shown in Fi g 4 . The keratinocyte stimulatory effect had peaked by 
24 h (Fig 4 , compare level of stimulation after 24 [33% ± 19], 48 
[27 % ± 17], and 72 h [43% ± 16]). 
The Keratinocyte Stimulation by T Cells Is Not Specific to 
psoriasis Supernatants from human immo rtal T-cell l!nes ~ere 
subsequently studied . The T-cell line MOLT-4, which IS den ved 
fro m peripheral blood from a patient With acute lymphoblastic leu-
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Figure 4. The keratinocyte-stimulating effect released from T-cell clones 
are at maximum at 24 h T-cell stimulation. The T-cell clone was stimulated 
with anti-CDw60 and the conditioned media were harvested from different 
wel ls after 24 (--), 48 ( -..:..- ), or 72 (-- """,) h and tested for keratino-
eyee growth-modulatory effect on the same keratinocyte source in the same 
experiment. ---, control medium incubated 24 h. -'-'-' , maximal kerati-
nocyte growth in completely supplemented keratinocyte medium (KGM); 
and _ .. _ .. _ .. _ .. _ , keratinocyte growth in semicompletcd medium 
(SKBM). 
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Figure 5. T~cell growth induction of keratinocytes is not specific to T ce lls 
cloned from II1 vo lved psoriatic epidermis, Twenty-four - hour supernatants 
(--) from the T ce ll lines MO LT-4 (lift m rlle) , C9 1/PL (middle m rve) , 
and CEM (nght CII nle) , and controlmcdium (-- -) were tested for ke ratinocytc 
growth induction in the fluorometric assay. The T-cell line MOLT-4 in-
duced kerannocyte growth whereas the rwo other cell lines did not, T his was 
the representative cxperiment of two experiments of each ce ll line using the 
same source of keratinocytes , 
ken~ia [14] , stimul ated keratinocyte growth. The keratinocyte stim-
ulatIOn IS sho~n as a dose-respo nse curve in Fig 5 (lift curve), Two 
other T-cell "~l es tested C91/ PL and CEM (Fig 5, middle and right 
CIIrves! respectively) did not stimulate keratinocyte growth . The 
keratmocyte growth-modulato ry effect o f these three T-cell lines 
were not affected by the addition of PHA and PMA (data no t 
shown) . 
The ability o f T cells to release g rowth factors that stimulate 
kerat1110cyte gr~wth is thus not specific to either epidermal T cells 
or psori aSIS. ~hls does not , however, eliminate th e possibility that 
T-cell 111ductlon o f keratinocyte grow th plays a significant ro le in 
the pathogenesis of psorias is. 
The Capacity of Various Cytokines to Modulate Keratino-
cyte Growth To investiga te which T-cell cyto kines could m edi-
ate the keratinocyte growth-stimul ato ry effect , addi t io n o f blocking 
antibodies to cyto kmes w as attempted. These experiments were 
abandoned because the assay sys tem proved very sensitive to the 
addition of antibodies . Even isotype control antibodies inhibited 
keratinocyte growth despite extensive dialys is of the antibody prior 
to addition to the keratinocytes (data not show n). 
Instead , several reco_mbinant humall cytokines w ere tested for 
growth-modulatory effect on the keratinocytes in this culture sys-
tem . These data are shown .by the dose-respo nse curves of the 
various cy tokl1~es tested 1\1 Fig 6 . The keratinocytes used fo r the 
~ytok111e expenments w ere the sam e as those used in Fig 2 and, 
Importantly , they responded with enhanced growth to the T -cell 
supernatant. The cyto~ines IL-2, IL-4, and IL-8 (Fi g 6, top l~(t, 
1I1Iddie left, and.bottom hft, respectively) had no effect o n keratinocyte 
growth m tl11S assay sys tem . The cytokines IFN-g and TGF-p 
downregulated keratinocyte growth in th e concentratio n ranges 
0 .01 -1000 Jll ml and 1-10 ng/ml , respectively (data no t shown) . 
Both IL-3 and GM-C SF (Fig 6 , top righI, bottom right) had a modest 
but reproducible growth-enhancin g effect o n keratinocyte growth , 
whereas IL-6 at low concentratio ns slig htly stimulated keratinocyte 
growth (Fig 6 , middle right) . The keratinocyte grow th-enh ancing 
effect of IL-3 and GM-C SF w as, however , o nly a small fractio n o f 
the substantial stimulatio n by the T-cell clone supernatants (Fig 2). 
To test whether a combination o f IL-3 and GM-C SF p resent at 
the same time in the supernatants could induce keratinocyte 
growth , the concentratio ns o f IL-3 and GM-C SF in various T-cell 
supernatants w ere m easured using ELISA kits. As shown in Fig 7, it 
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Figure 6. Keratinocyte growth-modulatory properties of various recombi-
nant human cytokines. The recombinant cytokines were diluted in SKBM 
and added to the keratinocytes cultured in SKBM. The keratinocytes were 
from the same so~rces that were found to be stimulated by the T-cell super-
natants. After 3 d mcubatton the relattve cell number was estimated using the 
fluorometnc assay. Note that IL-2, IL-4, and IL-8 alone do not induce 
~eratinocyte growth in. this assay system. IL-6 at low concentrations may 
mduce growt~ of keratmocytes, whereas IL-3 and GM-CSF induce slight 
(but repro?uclble) growth of keratinocytes. Each curve is representative of 
two expenments. 
is unlikely that either IL-3 or GM-CSF are responsible for the kerat-
inocyte growth stimulation. T-cell clone supernatants (PS1K4 and 
PS1K6, Fig 2) that induced keratinocyte growth as depicted on the 
y-axis of Fig 7 contained neither measurable IL-3 (Fig 7, top curve, 
dot, and triangle) nor GM-CSF (Fig 7, bottom ClIme, dot, and triarlgle) 
and thus contained far less than the amounts of rhIL-3 and rhGM-
CSF required for keratinocyte stimulation (Fig 7) . 
To test the possibility that the keratinocyte stimulatory effect was 
due to TGF-O', we measured the content ofTGF-O' in the T-cell 
supernatants. TGF-O' presence was below the detectable level (data 
not shown) in all of the T-cell supernatants. 
DISCUSSION 
The data presented in this article demonstrate both that T-cell 
clones are capable of releasing cytokines that stimulate growth of 
normal keratlllocytes a~d that T cells with this capability are present 
m.the skill III the keratlllocyte hyperproliferative skin disease psori-
aS Is. 
T cells have previously been postulated to re lease cytokines that 
stimulate keratinocyte growth [12]. However, T cells for those 
experiments were obtained from purified peripheral blood mono-
~1Uclear cells that contain contami~~nts of other cytokine-produc-
lllg cell types. Furthermore, dendntic cells were added to stimulate 
the purified T cells. Therefore, effects of supernatants harvested 
from these cells cannot with certainty be attributed to T cells. 
We demonstrate the keratinocyte growth-promoting effect to be 
released by T-cell clones consisting of pure T-cell populations. Al-
though we used autologous gamma-irradiated mononuclear cells as 
feeder cells, it is very unlikely that the cell types herein are conta-
minatants, because the T-cell clones were used for supernatant har-
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Figure 7. GM-CSF and IL-3 modulation of keratinocyte growth and 
ELISA-detem-uned concentratIOns of GM-CSF and IL-3 in selected T-cell 
supernatants. The x-axis depicts ELISA-determined content of IL-3 (top 
Cllrl/e) or GM-CSF (bottom Cllrl/e) of the T-ce ll supernatants from the T-cell 
clones: P~ 1 K4 (dot) , PS1K6 (triallgle), PS1K15 (square) (see Fig 1) and 
PS3K5 (diamond) . The cytokme concentrations are plotted against the ke-
ratmocyte modulatory effect of the respective T-cell clones expressed as 
percent of max1Inalmducibie growth. (--), keratinocyte growth-modu-
latory capacity of various concentrations of rhIL-3 (top CIIrve) and rhGM-
CSF (bottom CIIrve) . Error bars are mean ± SD of triplicate determinations. 
vesting at least 10 d later. The substantial expansion of the T-cell 
clones following stimulation and the heavy irradiation with 3600 
rads makes it even more unlikely that any feeder cells remain and are 
capable of producing cytokines. Furthermore, the T -cell line 
MOLT -4, whic.h does not exhibit reverse transcriptase activity, 
stimulated keratmocyte growth (Fig 5). This cell line is free from 
contaminating non-T cells. 
. The immune cellular infiltrate in psoriasis consists almost exclu-
Sively of T cells and antigen-presenting macrophages. In a culture 
system .almost identical to ours it has been shown that antigen-
present~ng cells are not capab.le of enhancing keratinocyte DNA 
sYI~thesl~ [12] . We have preVIOusly shown that lesional psoriatic 
epidermiS ~l~S an increased ability to stimulate autologous T cells 
and that tillS IS due to non-Langerhans antigen-presenting cells [l S]. 
It therefo~e s~ems probable that the macrophages in the psoriatic 
mfiltrate ~11 villa a~tlvate T cell s, which then enhance keratinocyte 
growth Ilia cytokme release. 
. Our observations that IL-6 and IL-S do not stimulate or barely 
stimulate. keratl11~cyte . growth (Fig 6) differ from .findings of other 
laboratones [19]. TI1lS may be explallled by a difference in assa 
systems. The IL-S investigation used an assay time of 2 weeks * 
which is l~Ot comparable to our 3-d system. In the IL-6 study [19] 
the expenments were performed with growth-arrested keratino-
cytes and the parameter measured was 3H-thymidine incorporation, 
• Reuch MK, St~dt~ann M, Schroder J-M, Sticherling M, Christophen 
E: NAP /Interleukm-8 IS a potent mitogen for human keratinocytes in vitrQ 
(abstr) . J Invest Dermato l 95:485, 1990 (abstr.) . 
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hich is not necessarily correlated with division of cells [20]' in 
w ntrast to the methods used in this paper, which are correlated to 
~~1l number. These differences in design may explain the conflict-
ing data. 
Our data confirm the observations by Hancock et 01 [12] that IL-3 
d GM-CSF could induce keratinocyte growth, but we found that 
~cell clones that stimulated keratinocyte growth contained unde-
table levels ofIL-3 and GM-CSF, suggesting that these cytokines ~~ unlikely to be responsible for the T-cell induction ofkeratino-
eyte growth. 
Although IFN-g contents were not measured in the conditioned 
dia from the T -cell clones, it may be assumed that at least some of ~e clones are IFN-g producers. Because IFN-g is known to inhibit ~e~atinocyte growth it may seem paradoxical that seven of e.ight 
I nes stimulate kerat1l10cyte growth. We measured the comb1I1ed 
c frect of all factors in the conditioned media from the T -cell clones. 
~ ossible growth-inhibitory effect from IFN-g may have been ov~rriden by the concurrent presence of keratinocyte growth-
stimulatory factors. 
The nature of the stimulus from the T cell s that induce keratino-
te proliferation remains elusive. One presently unidentified and 
cy sibly even unknown growth factor, or perhaps a combination of 
PO:eral growth factors, could be responsible. Such a combination of 
se eral growth factors could even include the cytokines that in this 
sev er were found not to stimulate keratinocyte growth alone. If the 
f?cell-derived keratinocyte stimulus is one growth factor, identifi-
ation is possible by fractionation. 
c The fact that the T-cell supernatants contained undetectable 
levels ofTGF-Cl', IL-3, and ~M-C~F does not exclude the possibil-
. that these cytokl11es partiCipate 111 the regulation of the keratlllo-
Ityte proliferation. TGF-Cl' and GM-CSF can be produced by kerati-
%cytes [21 ,22]. Thus, the T-cell supernatant might induce 
keratinocyte production of these cyto~ines, which then might stim-
I te keratinocyte growth III an autocnne manner. Alternatively, the ~ ~cell supernatant may induce the receptors for these cytok~nes, 
thus increasing the sensitivity of the keratinocytes to the cytokllles, 
resul ting in increased growth. At ~east With rega~d .to TGF-Cl', this 
h pothesis is supported by the find1l1g that III psonas Ls both the EGF 
r!ceptor [23] and its li.gand, TGF-Cl', are o~erexpressed [24]. In tim 
nnection we found 111 preltm1l1ary expenments that T -cell super-
co tants stimulating keratinocyte growth increased keratinocyte ex-
na ssion of EGF receptor by 13% as measured by flow cytometric ~:lys is. Thus the . keratinocyt~-stimulating activity from lesional 
soriatic T cells 111L ght be mediated through the TGF-Cl'-EGF re-~eptor system, in spite of the fact that the T-cell supernatants did not 
contain any TGF-Cl'. . 
Only eight of 40 clones grew to suffiCient numbers. to execute 
experiments. Whether these eight clones are representative of the T 
cells in the psoriatic lesion in terms ofkeratlllocyte growth modu la-
tion is unknown. However, T-cell clones obtallled With thiS 
method exhibit the same CD4/CD8 ratio as the T cells itl siw [9] , 
which suggests that the T-cell clones may be representative of T 
cells in the psoriatic lesion. The final proof awaits identification of 
the keratinocyte-stimulatory factor(s) and demonstration of the 
presence of this/these factor(s) in situ. 
We have shown that lesional psoriatic T-cell clones in vitro have 
rhe capacity to secrete growth factors that stimulate keratinocyte 
growth. Whether the same process o.ccurs i" l: iIlO. re~a1l1s to be 
elucidated. The growth rate of keratlllocytes It! SltH IS less than 
maximal and .we have attempted to mimic this charact~ristic by 
using sub-optimal addltlon of growth factors to our medium. We 
have circumstantial evidence that lesional psoriatic T cells release 
cytokines in 1Ii110. Clusters oflesional psoriatic keratinocytes express 
rhe surface molecule HLA-DR [25]. The only cytokine known to be 
able to induce HLA-DR 011 keratinocytes is IFN-g [26], and the 
only cell type known to produce IFN-g is the T-Iymphocyte. Thus, 
rhe presence of HLA-DR+ keratinocytes suggests that IFN-g is 
locally produced by T cells. The point is underscored by rhe demon-
strated presence in vivo of enhanced levels of IFN-g in involved 
psoriatic skin [27] and the finding that lesional psoriatic T cells with 
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the capacity to release IFN-g itl lIilro induce HLA-DR and other 
surface molecules characteristic of the psoriatic phenotype on nor-
mal keratinocytes [9] . 
In this paper, we have provided evidence to support the hypothe-
sis that T cells playa pivotal role in the pathogenesis of psoriasis and 
that the T -cell - derived keratinocyte growth-promoting effect is 
not specific to psoriasis. Many dermatoses are characterized by the 
presence of activated T cells, e.g., contact dermatitis, lichen planus, 
atopic dermatitis, and cutaneous T-cell lymphoma concurrent with 
epidermal hyperplasia. We propose that T-cell-derived cytokines 
play an important role in the generation of the epidermal hyperpla-
sia in the~e diseases and that this common pathway is upregulated in 
psonasls 111 particular, leading to the extreme epidermal hyperplasia. 
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